Vialwirebiotech, curated
November 21, 2026, 5:40 AM
November 14, 2026
- 6:00 AM · FT — Pharmaceuticals6:00 AMMakers of obesity drugs hit back at claims of negative side effects — FT — Pharmaceuticals
November 13, 2026
- 2:53 PM · Pharmaceutical Technology2:53 PMAHA26: Boehringer’s survodutide establishes CV safety in SYNCHRONIZE-CVOT — Pharmaceutical Technology
- 11:07 AM · Pharmaceutical Technology11:07 AMAHA26: Semaglutide’s real-world CV benefits highlight importance of persistence — Pharmaceutical Technology
- 11:00 AM · BioWorld11:00 AMBracco, Avicenna.ai win FDA nod for AI-driven brain aneurysm tool — BioWorld
- 11:00 AM · BioWorld11:00 AMNeurosterix’s NTX-253 for schizophrenia draws $105M, Karuna vets — BioWorld
- 11:00 AM · BioWorld11:00 AMBiopharma deal value hits eight-year high as October M&A stalls — BioWorld
- 10:25 AM · STAT News10:25 AMSTAT+: HHS plans funding for research into ibogaine for PTSD — STAT News
- 9:39 AM · Pharmaceutical Executive9:39 AM<![CDATA[Eli Lilly Breaks Ground on $3.5 billion Pennsylvania Manufacturing Site]]> — Pharmaceutical Executive
- 9:36 AM · BioPharma Dive9:36 AMNovo submits sickle cell drug; Flagship, Gates Foundation deepen ties — BioPharma Dive
- 8:00 AM · BioWorld8:00 AMImpact Therapeutics patents new PARP-1/Topo I inhibitors — BioWorld
- 8:00 AM · BioWorld8:00 AMSudo Biosciences discloses new TYK2 degradation inducers — BioWorld
- 8:00 AM · BioWorld8:00 AMCatalytic inhibition of METTL1 against several aggressive malignancies — BioWorld
- 8:00 AM · BioWorld8:00 AMDual-targeting CD19/BCMA in vivo CAR T therapy for autoimmune diseases — BioWorld
- 8:00 AM · BioWorld8:00 AMVor Bio licenses Remegen’s BAFF/APRIL inhibitor RC-298 — BioWorld
- 8:00 AM · BioWorld8:00 AMGuangzhou Joyo Pharmatech reports new ADCs — BioWorld
- 8:00 AM · BioWorld8:00 AMYD Bio seeks FDA guidance on YDB-LMSCEV-001 for dry eye disease — BioWorld
- 8:00 AM · BioWorld8:00 AMFrench researchers identify new SIGMAR1 ligands — BioWorld
- 8:00 AM · BioWorld8:00 AMUniversität Zürich discovers new GPR84 agonists — BioWorld
- 8:00 AM · BioWorld8:00 AMFDA clears IND for Biolojic’s multibody-drug conjugate — BioWorld
- 6:40 AM · Pharmaceutical Technology6:40 AMFDA puts commissioner’s priority voucher framework on ice — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMPhaSER receives $2.7 million to grow company — Drug Discovery World